A low burden device for Ebola virus antigen detection
Please note that for mobiles we stream the presentation slides and audio of the speaker.
Dr Steve Lonsdale offers an overview of Ebola viruses and their species and symptoms, before describing how the development of a lateral flow immunoassay device came about in response to the recent Ebola crisis in West Africa.
Dr Naomi Walker weighs the new device up against previous methods of Ebola detection in the region, and offers data from the trial study conducted to test the device in Sierra Leone.
This lecture was part of the '11th Medical Innovations summit' at The Royal Society of Medicine in London.
Date of lecture: 12th September 2015